Clustered nanobody–drug conjugates for targeted cancer therapy
Tiantian Wu, Manman Liu, Hai Huang, Yaping Sheng, Haihua Xiao, Yangzhong Liu
Abstract
A clustered Nb-drug conjugate (cNDC@PEG) was designed using anti-EGFR Nb to specifically deliver Pt(iv) prodrugs to tumors. cNDC@PEG efficiently targets EGFR positive tumor cells, and the clustered cNDC@PEG is more efficient in inhibiting tumor growth in vivo than the monomeric NDC. This work provides a novel strategy for the construction of a multi-valent NDC using dendrimers.
Topics & Concepts
ConjugateDrugAntibody-drug conjugateChemistryLysineCancerPharmacologyCancer researchCombinatorial chemistryMedicineAntibodyBiochemistryImmunologyMonoclonal antibodyAmino acidInternal medicineMathematical analysisMathematicsMonoclonal and Polyclonal Antibodies ResearchAdvanced biosensing and bioanalysis techniquesNanoparticle-Based Drug Delivery